397 related articles for article (PubMed ID: 34351418)
1. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
Hoch NC
Biochem Soc Trans; 2021 Aug; 49(4):1711-1721. PubMed ID: 34351418
[TBL] [Abstract][Full Text] [Related]
2. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
[TBL] [Abstract][Full Text] [Related]
3. ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
Yu L; Liu X; Yu X
J Zhejiang Univ Sci B; 2021 Jan; 22(1):21-30. PubMed ID: 33448184
[TBL] [Abstract][Full Text] [Related]
4. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
[TBL] [Abstract][Full Text] [Related]
5. The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase.
Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
J Virol; 2021 Jan; 95(3):. PubMed ID: 33158944
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
J Biol Chem; 2020 Dec; 295(52):17986-17996. PubMed ID: 33051211
[TBL] [Abstract][Full Text] [Related]
7. The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation.
Alhammad YMO; Fehr AR
Viruses; 2020 Mar; 12(4):. PubMed ID: 32244383
[TBL] [Abstract][Full Text] [Related]
8. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
[TBL] [Abstract][Full Text] [Related]
9. The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.
Fehr AR; Singh SA; Kerr CM; Mukai S; Higashi H; Aikawa M
Genes Dev; 2020 Mar; 34(5-6):341-359. PubMed ID: 32029454
[TBL] [Abstract][Full Text] [Related]
10. Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential.
Rack JGM; Zorzini V; Zhu Z; Schuller M; Ahel D; Ahel I
Open Biol; 2020 Nov; 10(11):200237. PubMed ID: 33202171
[TBL] [Abstract][Full Text] [Related]
11. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts.
Daugherty MD; Young JM; Kerns JA; Malik HS
PLoS Genet; 2014; 10(5):e1004403. PubMed ID: 24875882
[TBL] [Abstract][Full Text] [Related]
12. The Antiviral Activities of Poly-ADP-Ribose Polymerases.
Malgras M; Garcia M; Jousselin C; Bodet C; Lévêque N
Viruses; 2021 Mar; 13(4):. PubMed ID: 33808354
[TBL] [Abstract][Full Text] [Related]
13. Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis.
Fehr AR; Jankevicius G; Ahel I; Perlman S
Trends Microbiol; 2018 Jul; 26(7):598-610. PubMed ID: 29268982
[TBL] [Abstract][Full Text] [Related]
14. The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases.
Eckei L; Krieg S; Bütepage M; Lehmann A; Gross A; Lippok B; Grimm AR; Kümmerer BM; Rossetti G; Lüscher B; Verheugd P
Sci Rep; 2017 Feb; 7():41746. PubMed ID: 28150709
[TBL] [Abstract][Full Text] [Related]
15. When PARPs Meet Antiviral Innate Immunity.
Zhu H; Zheng C
Trends Microbiol; 2021 Sep; 29(9):776-778. PubMed ID: 33483164
[TBL] [Abstract][Full Text] [Related]
16. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
Alhammad YMO; Kashipathy MM; Roy A; Gagné JP; McDonald P; Gao P; Nonfoux L; Battaile KP; Johnson DK; Holmstrom ED; Poirier GG; Lovell S; Fehr AR
bioRxiv; 2020 Oct; ():. PubMed ID: 32511412
[TBL] [Abstract][Full Text] [Related]
17. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
[TBL] [Abstract][Full Text] [Related]
18. Binding Adaptation of GS-441524 Diversifies Macro Domains and Downregulates SARS-CoV-2 de-MARylation Capacity.
Tsika AC; Gallo A; Fourkiotis NK; Argyriou AI; Sreeramulu S; Löhr F; Rogov VV; Richter C; Linhard V; Gande SL; Altincekic N; Krishnathas R; Elamri I; Schwalbe H; Wollenhaupt J; Weiss MS; Spyroulias GA
J Mol Biol; 2022 Aug; 434(16):167720. PubMed ID: 35839840
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
Stoll GA; Nikolopoulos N; Zhai H; Zhang L; Douse CH; Modis Y
J Virol; 2024 Feb; 98(2):e0177723. PubMed ID: 38289106
[TBL] [Abstract][Full Text] [Related]
20. PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation.
Ribeiro VC; Russo LC; Hoch NC
EMBO J; 2024 Jun; ():. PubMed ID: 38834852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
